India's SENSEX stock index is on a 3-month consecutive rise.

On Friday morning, the Indian stock market rose by 187 points (0.2%) to reach 82,322 dollars, rising for 9 consecutive sessions and hitting a record high.

Nifty50 surpassed 25,200, with pharmaceuticals, health care, and a-reit etf on the rise by 0.4%.

Nifty50 set an all-time high in the monthly F&O settlement session on August 29, continuing to outperform Bank Nifty. The index has maintained an upward momentum for 11 consecutive sessions, and the momentum indicators are maintaining a positive bias. The financial estimates for the Nifty50 index target 25,300 in the near term, followed by 25,500 in the September series, with the 25,000-24,950 zone expected to provide resistance. A close above the 25,150 level would indicate a bullish sentiment and suggest the possibility of a continued short-term uptrend.

Traders maintained a bullish momentum as they awaited the release of the US PCE Price Index, which the Federal Reserve Board (FRB) frequently uses as a clue for the monetary policy outlook.

At the top, there were veru inc (2.5%), Devices Laboratories (1.9%), BPCL (1.6%), Adani Enterprises (1.5%), and others.

However, investors are awaiting the release of India's GDP for the second quarter later today.

Still, supported by optimism that the US Federal Reserve may cut interest rates next month, the market is heading towards three consecutive weekly and monthly gains.